Inborn and acquired metabolic defects in cancer

Christian Frezza, Patrick J Pollard, Eyal Gottlieb

Research output: Contribution to journalArticlepeer-review


The observation that altered metabolism is the fundamental cause of cancer was made by Otto Warburg nearly a century ago. However, the subsequent identification of oncogenes and tumor suppressor genes has displaced Warburg's theory pointing towards genetic aberrations as the underlining cause of cancer. Nevertheless, in the last decade, cancer-associated mutations have been identified in genes coding for tricarboxylic acid cycle (TCA cycle, also known as Krebs cycle) and closely related enzymes that have essential roles in cellular metabolism. These observations have revived interest in Warburg's hypothesis and prompted a flurry of functional studies in the hope of gaining mechanistic insight into the links between mitochondrial dysfunction, metabolic alterations, and cancer. In this review, we discuss the potential pro-oncogenic signaling role of some TCA cycle metabolites and their derivatives (oncometabolites). In particular, we focus on their effects on dioxygenases, a family of oxygen and α-ketoglutarate-dependent enzymes that control, among other things, the levels and activity of the hypoxia-inducible transcription factors and the activity of DNA and histone demethylases.
Original languageEnglish
Pages (from-to)213-20
Number of pages8
JournalJournal of Molecular Medicine
Issue number3
Publication statusPublished - Mar 2011


  • Animals
  • Citric Acid Cycle
  • Fumarate Hydratase
  • Humans
  • Isocitrate Dehydrogenase
  • Models, Biological
  • Neoplasms
  • Succinate Dehydrogenase

Fingerprint Dive into the research topics of 'Inborn and acquired metabolic defects in cancer'. Together they form a unique fingerprint.

Cite this